PrimeRFP SCOUT · Federal Contract Recompete Brief

HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23

Contract75N91018F00071

HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23 is a federal award for Department of Health and Human Services (HHS) held by LEIDOS BIOMEDICAL RESEARCH, INC.. Estimated value $67.0M ($48.3M obligated). Current period of performance ends Aug 31, 2027.

$67.0M
Estimated Value
$48.3M
Obligated
Aug 31, 2027
PoP End / Expires
More in SCOUT — score this to your firm →See related expiring contracts →
AnalysisPublic

LEIDOS BIOMEDICAL RESEARCH, INC. holds $2.3B across 187 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 3 related awards under parent HHSN261201500003I. Recompete timing centers on the Aug 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Contract factsFederal
Contract number75N91018F00071
AgencyDepartment of Health and Human Services (HHS)
IncumbentLEIDOS BIOMEDICAL RESEARCH, INC.
UEIHV8BH9BPG8Y9
NAICS561210
PSCM1HA
Parent IDIQ / IDVHHSN261201500003I
PoP end (current)Aug 31, 2027
Obligated$48.3M

HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23

Recompete timingPublic
Expiring in 400 days

Current PoP ends Aug 31, 2027 (400 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Track recompete timing in SCOUT →
Incumbent footprintPublic record

LEIDOS BIOMEDICAL RESEARCH, INC.$2.3B obligated across 187 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Open full company profile
Related awardsSame parent · incumbent
75N91018F00073
PDX PANELS FROM COMMON TUMORS
$67.9M
Sep 25, 2027
75N91018F00059
EBOLA VIRUS AND OTHER INFECTIOUS DISEASES
$64.9M
Sep 21, 2028
75N91018F00077
CELL-BASED IMMUNOTHERAPY PRODUCTS
$53.5M
Aug 29, 2029

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Score this to your firm →

Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open LEIDOS BIOMEDICAL RESEARCH, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HHSN261201500003I-75N91018F00071